DNMT3A and gastric cancer: These findings add diverse roles and mechanistic insight into our understanding of DNMT3A, define DNMT3Ab as a potential target for predicting clinical outcomes for patients, and may potentially lead to the development of novel strategies aimed at the prevention or early treatment of GC progression.